Compare Stocks

Galiano Gold Inc. engages in the exploration, development, and production of gold properties. It operates and manages the Asanko Gold Mine, which is located in Ghana, West Africa. The company was formerly known as Asanko Gold Inc. and changed its name to Galiano Gold Inc. in May 2020. Galiano Gold Inc. was incorporated in 1999 and is headquartered in Vancouver, Canada.

The USCF Gold Strategy Plus Income Fund (GLDX) is an exchange-traded fund that mostly invests in gold commodities. The fund is actively managed, aiming to provide gold exposure while generating income through a gold covered call writing strategy and collateral interest income. GLDX was launched on Nov 3, 2021 and is managed by USCF Advisers.

23andMe Holding Co. operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. This segments also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; and offers research services. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to enhance patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing intellectual property associated with identified drug targets related to drug candidates under clinical development. The company's therapeutics product portfolio comprises 23ME-00610 (P006), a humanized monoclonal antibody, which is in phase 1/2a clinical trials to interfere with the ability of CD200R1 to interact with CD200 in cancer cells; and GSK6097608, an antibody that targets CD96 for attenuating T and NK cell anti-tumor immune responses. The company was incorporated in 2006 and is headquartered in South San Francisco, California.

Thor Explorations Ltd., together with its subsidiaries, produces and explores gold and silver deposits. Its flagship property is the Segilola Gold Project in Nigeria. The company was incorporated in 1968 and is based in Vancouver, Canada.

West African Resources Limited engages in the acquisition, exploration, and development of mineral resource projects in West Africa. The company explores for gold and copper. Its key asset is the 100% owned Sanbrado gold project located in Burkina Faso. The company was incorporated in 2006 and is based in Subiaco, Australia.